Binfeng Chen
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Immunology 13
- Immune Cell Function and Interaction 6
- interferon and immune responses 4
- T-cell and B-cell Immunology 3
-
- Influenza Virus Research Studies 5
- Inflammatory Myopathies and Dermatomyositis 2
- Co-authors
- Yi Zhao (1 shared paper)Jun Guo (1 shared paper)Wei‐jie Guan (1 shared paper)Ailan Chen (1 shared paper)Nuofu Zhang (1 shared paper)Yimin Li (1 shared paper)Jiatao Lu (1 shared paper)Yuanda Xu (1 shared paper)
- Journals
- Molecular Therapy (2 papers)European Journal of Medicinal Chemistry (2 papers)Frontiers in Immunology (2 papers)Clinical and Translational Medicine (2 papers)Cell Metabolism (1 paper)
- Partner nations
- ChinaJapanSouth Korea
In The Last Decade
Binfeng Chen
24 papers receiving 1.1k citations
Binfeng Chen's Hit Papers
Peers
Comparison fields: 5 of 119
- Infectious Diseases 596
- Neurology 254
- Critical Care and Intensive Care Medicine 75
- Health Informatics 19
- Radiology, Nuclear Medicine and Imaging 220
Countries citing papers authored by Binfeng Chen
This map shows the geographic impact of Binfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binfeng Chen more than expected).
Fields of papers citing papers by Binfeng Chen
This network shows the impact of papers produced by Binfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binfeng Chen. The network helps show where Binfeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Binfeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 Hit paper breakdown → | 2020 | 829 |
| 2 | 2022 | 43 | |
| 3 | 2023 | 33 | |
| 4 | 2016 | 23 | |
| 5 | 2022 | 22 | |
| 6 | 2022 | 20 | |
| 7 | 2022 | 19 | |
| 8 | 2024 | 16 | |
| 9 | 2022 | 14 | |
| 10 | 2018 | 13 | |
| 11 | 2014 | 13 | |
| 12 | 2019 | 12 | |
| 13 | 2022 | 8 | |
| 14 | 2019 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2024 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2023 | 2 |
About Binfeng Chen
Binfeng Chen is a scholar working on Immunology, Epidemiology, Molecular Biology, Rheumatology and Electronic, Optical and Magnetic Materials, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Influenza Virus Research Studies (5 papers), interferon and immune responses (4 papers), Iron-based superconductors research (3 papers), T-cell and B-cell Immunology (3 papers), Systemic Lupus Erythematosus Research (3 papers), Inflammatory Myopathies and Dermatomyositis (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Infectious Diseases (596 citations), Neurology (254 citations), Critical Care and Intensive Care Medicine (75 citations), Health Informatics (19 citations) and Radiology, Nuclear Medicine and Imaging (220 citations). Binfeng Chen has collaborated with scholars based in China, Japan and South Korea. Frequent co-authors include Yi Zhao, Jun Guo, Wei‐jie Guan, Ailan Chen, Nuofu Zhang, Yimin Li, Jiatao Lu, Yuanda Xu, Limin Ou and Haiyan Guo. Their work appears in journals such as Molecular Therapy, European Journal of Medicinal Chemistry, Frontiers in Immunology, Clinical and Translational Medicine and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.